Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 305–305 | Cite as

Nivolumab

Hyperprogressive disease of non small cell lung cancer as a paradoxical reaction: case report
Case report
  • 1 Downloads

Reference

  1. Huang X, et al. Treatment of Nivolumab Results in Hyperprogressive Disease in a Patient Harboring EGFR Exon 20 Insertion and MYC Amplification. Journal of Thoracic Oncology 14: e189-e191, No. 9, Sep 2019. Available from: URL: http://doi.org/10.1016/j.jtho.2019.04.009 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations